Admin Core
Admin Core
批准号:
10673922
负责人:
David A Barbie
金额:
$31.22万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
未结题
起止时间:
2022-08-01 至 2027-07-31
关键词:
AdministratorAdultAwardCancer CenterCancer PatientClinicalClinical ResearchClinical TrialsCollaborationsCommunitiesComprehensive Cancer CenterCore FacilityDana-Farber Cancer InstituteData Management ResourcesDevelopmentEnsureEvaluationFundingGenomicsGoalsGrantGuidelinesHospitalsIndividualInstitutionInstitutional Review BoardsIntellectual PropertyInvestigationJointsLaboratoriesLeadershipLicensingLinkLungMalignant neoplasm of lungMedicalMonitorNewly DiagnosedOffice of Administrative ManagementPatient advocacyPatientsPlasmaPrincipal InvestigatorProceduresProcessProductivityProperty RightsProtocols documentationQualifyingReportingResearchResearch PersonnelResourcesSecureSpecialistStructureTalentsTechnologyTissuesTranslational ResearchVisionWorkWritinganticancer researchbiobankcareercostdata sharingexperienceflexibilityimplementation facilitationmeetingsmembernew technologypatient populationprogramsrecruittranslational goal
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY
The goals of the Administrative Core are to facilitate implementation of the overall vision of this SPORE
and its constituent projects, cores and programs. This work will be carried out by a governing body
comprised of the SPORE leadership and key members of the DF/HCC. Both Dr. Sequist and Dr. Barbie
are highly qualified co-directors of the Lung SPORE Program with a strong track-record of research
productivity in translational and laboratory-based investigation. In addition to the talented team of Lung
Cancer SPORE investigators, they have further assembled a well-qualified Governance Committee,
Patient Advocacy Committee, Internal and External Advisory Boards, and Project and Grants
Administrators to support them in this endeavor. Among other tasks, this will include oversight and
monitoring of research progress, facilitation of collaborations, and development of a flexible research
program that ensures maximum translational focus. In addition, they have secured substantial
additional institutional resources to supplement the proposed research, both covering the costs of
expensive novel technologies and supporting additional Career Enhancement and Developmental
Research Program Grants. The overall purpose of the Administrative Core is thus to coordinate and
operationalize all of the individual components of the DF/HCC Lung Cancer SPORE Program and to
provide administrative and fiscal oversight.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Project 2
-
批准号:10673932
-
项目类别:
-
资助金额:$37.98万
-
财政年份:2022
-
负责人:David A Barbie
-
依托单位:
Dana Farber/Harvard Cancer Center SPORE in Lung Cancer
-
批准号:10673920
-
项目类别:
-
资助金额:$218.92万
-
财政年份:2022
-
负责人:David A Barbie
-
依托单位:
Pathology & Genomics
-
批准号:10673949
-
项目类别:
-
资助金额:$30.6万
-
财政年份:2022
-
负责人:David A Barbie
-
依托单位:
Development of Physiologic Tissue Models to Assess Tumor Explant Response to Immune Checkpoint Blockade
-
批准号:10250392
-
项目类别:
-
资助金额:$82.64万
-
财政年份:2017
-
负责人:David A Barbie
-
依托单位:
Targeting the cytokine circuitry of KRAS-driven lung cancer
-
批准号:10424442
-
项目类别:
-
资助金额:$40.74万
-
财政年份:2015
-
负责人:David A Barbie
-
依托单位:
Targeting the cytokine circuitry of KRAS-driven lung cancer
-
批准号:9042321
-
项目类别:
-
资助金额:$39.46万
-
财政年份:2015
-
负责人:David A Barbie
-
依托单位:
Targeting the cytokine circuitry of KRAS-driven lung cancer
-
批准号:10172854
-
项目类别:
-
资助金额:$41.57万
-
财政年份:2015
-
负责人:David A Barbie
-
依托单位:
Targeting the cytokine circuitry of KRAS-driven lung cancer
-
批准号:10670932
-
项目类别:
-
资助金额:$40.74万
-
财政年份:2015
-
负责人:David A Barbie
-
依托单位:
Targeting the cytokine circuitry of KRAS-driven lung cancer
-
批准号:9263834
-
项目类别:
-
资助金额:$39.46万
-
财政年份:2015
-
负责人:David A Barbie
-
依托单位:
Synthetic-Lethal-Based Targeted Therapy for Oncogenic KRAS-Driven Cancer
-
批准号:8317974
-
项目类别:
-
资助金额:$17.82万
-
财政年份:2010
-
负责人:David A Barbie
-
依托单位:
Synthetic-Lethal-Based Targeted Therapy for Oncogenic KRAS-Driven Cancer
-
批准号:8530978
-
项目类别:
-
资助金额:$17.82万
-
财政年份:2010
-
负责人:David A Barbie
-
依托单位:
Synthetic-Lethal-Based Targeted Therapy for Oncogenic KRAS-Driven Cancer
-
批准号:7990096
-
项目类别:
-
资助金额:$17.82万
-
财政年份:2010
-
负责人:David A Barbie
-
依托单位:
Synthetic-Lethal-Based Targeted Therapy for Oncogenic KRAS-Driven Cancer
-
批准号:8133466
-
项目类别:
-
资助金额:$17.82万
-
财政年份:2010
-
负责人:David A Barbie
-
依托单位:
海外基金